Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Arcadia Biosciences revenue
Arcadia Biosciences's revenue is $5.0 million.
What is Arcadia Biosciences's revenue?
- Arcadia Biosciences's revenue growth from 2014 to 2024 is -27.74%.
- Arcadia Biosciences has 42 employees, and the revenue per employee ratio is $120,119.
- Arcadia Biosciences's peak quarterly revenue was $7.1M in 2020(q4).
- Arcadia Biosciences peak revenue was $8.0M in 2020.
- Arcadia Biosciences annual revenue for 2023 was 4.5M, -39.96% growth from 2022.
- Arcadia Biosciences annual revenue for 2024 was 5.0M, 13.27% growth from 2023.
On this page
Zippi applies for you, and finds you a job.
Arcadia Biosciences historical revenue
Arcadia Biosciences's peak revenue was $8.0M in 2020. The peak quarterly revenue was $7.1M in 2020(q4).
Arcadia Biosciences's revenue increased from $7.0m in 2014 to $5.0M currently. That's a -27.74% change in annual revenue.
Arcadia Biosciences annual revenue
Arcadia Biosciences annual revenue over time
| Fiscal year / year | Arcadia Biosciences revenue |
|---|---|
| 2014 | $7.0M |
| 2015 | $5.4M |
| 2016 | $3.2M |
| 2017 | $4.0M |
| 2018 | $1.5M |
| 2019 | $1.2M |
| 2020 | $8.0M |
| 2021 | $6.8M |
| 2022 | $7.4M |
| 2023 | $4.5M |
| 2024 | $5.0M |
Rate Arcadia Biosciences' financial transparency
Arcadia Biosciences annual growth
Arcadia Biosciences saw the greatest revenue growth in 2020, when revenue increased by 587.25%.
Arcadia Biosciences had the lowest revenue growth in 2018, when revenue changed by -63.64%.
Arcadia Biosciences annual growth rate over time
| Year | Arcadia Biosciences growth |
|---|---|
| 2015 | -22%↓ |
| 2016 | -41%↓ |
| 2017 | 26%↑ |
| 2018 | -64%↓ |
| 2019 | -20%↓ |
| 2020 | 587%↑ |
| 2021 | -16%↓ |
| 2022 | 9%↑ |
| 2023 | -40%↓ |
| 2024 | 13%↑ |
Arcadia Biosciences quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Arcadia Biosciences quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2014 | - | - | - | $2.8M |
| 2015 | $815,000 | $1.4M | $1.8M | $1.3M |
| 2016 | $852,000 | $721,000 | $1.1M | $540,000 |
| 2017 | $1.0M | $991,000 | $589,000 | $1.4M |
| 2018 | $214,000 | $436,000 | $370,000 | $444,000 |
| 2019 | $158,000 | $203,000 | $392,000 | $416,000 |
| 2020 | $309,000 | $281,000 | $314,000 | $7.1M |
| 2021 | $828,000 | $1.4M | $2.4M | $2.2M |
| 2022 | $3.2M | $3.9M | $1.6M | $744,000 |
| 2023 | $1.2M | $1.3M | $1.3M | $1.7M |
| 2024 | $1.3M | $1.3M | $1.5M | $1.2M |
Arcadia Biosciences jobs nearby
Do you work at Arcadia Biosciences?
Did Arcadia Biosciences meet its revenue projections?
Arcadia Biosciences financial information
| CEO | Stan Jacot |
| Industry | Consumer Staples |
| Company Type | Public |
| Employees Number | 42 |
| Date Founded | 2002 |
| Headquarters | Davis, California |
| Number of Locations | 1 |
| Revenue | $5.0M |
| Net Income | -$15,376,000 |
| Gross Proft | $2.1M (2024) |
| PE Ratio | -2.40 |
| Tax Rate | -0.0% |
| Market Capitalization | $16.9M |
| Total Assets | $28,922,000 |
| Ticker | RKDA |
Arcadia Biosciences jobs you might like
Arcadia Biosciences financing
Arcadia Biosciences received early financing of $18.0M on 2005-06-15.
| Series | Round size | Date |
|---|---|---|
| Private Equity | $18M | 06/2005 |
| Private Equity | $15M | 10/2008 |
| Private Equity | $25M | 04/2010 |
| Series D | $33M | 05/2014 |
| Post Ipo Debt | $25M | 12/2015 |
| Post Ipo Equity | $7.5M | 06/2019 |
| Post Ipo Equity | $9.2M | 09/2019 |
| Post Ipo Equity | $6.8M | 05/2020 |
| Post Ipo Equity | $25.1M | 01/2021 |
Arcadia Biosciences investors
| Investors | Security type |
|---|---|
| Saints Capital | Private Equity |
| BASF Venture Capital | Private Equity |
| CMEA Ventures | Private Equity |
| Saints Capital | Series D |
| CMEA Capital | Series D |
| BASF Venture Capital | Series D |
| Mandala Capital | Series D |
| Silicon Valley Bank | Post Ipo Debt |
Arcadia Biosciences competitors
Arcadia Biosciences's top competitor, Merck, earned an annual revenue of $64.2B.
Arcadia Biosciences's smallest competitor is Magee-Womens Research Institute & Foundation with revenue of $830.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Icos | $74,536 | $71.4M | 700 | - |
| Gilead Sciences | $99,828 | $28.8B | 11,800 | 525 |
| Merck | $90,328 | $64.2B | 74,000 | 1,751 |
| Whole Foods Market | $32,699 | $16.0B | 91,000 | 1,560 |
| American Council on Science and Health | $45,297 | $1.3M | 16 | - |
| Aurora Cannabis | $57,094 | $55.2M | 2,779 | - |
| Codexis | $80,636 | $59.3M | 165 | 12 |
| Donald Danforth Plant Science Center | $48,460 | $17.2M | 100 | - |
| Amgen | $93,349 | $33.4B | 22,000 | 500 |
| Mendel Biotechnology | $60,187 | $13.0M | 125 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Arcadia Biosciences highest paying jobs
Zippia gives an in-depth look into the details of Arcadia Biosciences, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Arcadia Biosciences. The employee data is based on information from people who have self-reported their past or current employments at Arcadia Biosciences. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Arcadia Biosciences. The data presented on this page does not represent the view of Arcadia Biosciences and its employees or that of Zippia.
Arcadia Biosciences may also be known as or be related to ARCADIA BIOSCIENCES INC., Arcadia Biosciences, Arcadia Biosciences Inc and Arcadia Biosciences, Inc.